Yahoo
NYSEArca - Delayed Quote USD

iShares U.S. Technology ETF (IYW)

253.31 +0.77 (+0.30%)
At close: September 4 at 4:00:00 PM EDT
253.08 -0.23 (-0.09%)
After hours: September 4 at 7:43:07 PM EDT
Trade IYW on Coinbase
Chart Range Bar
Loading chart for IYW
  • Previous Close 252.54
  • Open 253.71
  • Bid 252.44 x 10000
  • Ask 253.23 x 40000
  • Day's Range 252.44 - 254.32
  • 52 Week Range 172.54 - 261.01
  • Volume 259,507
  • Avg. Volume 602,043
  • Net Assets 25.22B
  • NAV 252.56
  • PE Ratio (TTM) 29.49
  • Yield 0.10%
  • YTD Daily Total Return 26.55%
  • Beta (5Y Monthly) 1.50
  • Expense Ratio (net) 0.37%

The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the technology sector of the U.S. equity market, as defined by FTSE Russell. The fund is non-diversified.

iShares

Fund Family

Technology

Fund Category

25.22B

Net Assets

2000-05-15

Inception Date

Performance Overview

View More

Trailing returns as of 9/3/2026. Category is Technology.

YTD Return

IYW
26.55%
Category
13.51%

1-Year Return

IYW
39.07%
Category
54.99%

3-Year Return

IYW
31.54%
Category
27.86%

People Also Watch

Holdings

View More

Top 10 Holdings (64.13% of Total Assets)

Symbol Company % Assets
NVDA 14.21%
AAPL 12.77%
MSFT 11.04%
GOOGL 5.57%
GOOG 4.50%
AVGO 4.16%
META 3.69%
MU 3.28%
AMD 2.86%
PLTR 2.04%

Sector Weightings

Research Reports

View More
  • Biogen Is Repositioning Its Portfolio To Partly Offset Ongoing Revenue Declines

    Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

    Rating
    Price Target
  • AI momentum continuing

    Broadcom Inc. is a top five global fabless semiconductor company with leading franchises in wired and wireless communications, enterprise data center and storage, and other end markets. The former Avago acquired Broadcom for $37 billion in 2016 and changed its name to Broadcom Inc. The company has grown via hardware acquisitions, including Agere, LSI Logic, Brocade, and Emulex; and software acquisitions, including CA Inc. in November 2018 and Symantec's enterprise security business in November 2019. Broadcom completed the acquisition of VMware in December 2023.

    Rating
    Price Target
  • Broadcom Earnings: Bullish 2028 Outlook

    Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

    Rating
    Price Target
  • Berkshire Hathaway: Purchases Outweighed Sales; Alphabet Saw Most Activity in Second Quarter

    Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from its operations to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis. Berkshire generated close to $371.4 billion in operating revenue in during 2025.

    Rating
    Price Target

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: